CAAS Capital Management’s Eli Lilly LLY Stock Holding History

CAAS Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$1.36M	Sell	1,650 -758	-31%	-$631K	0.15%	146
2024 Q4	$1.86M	Sell	2,408 -1,460	-38%	-$1.21M	0.33%	64
2024 Q3	$3.43M	Buy	3,868 +2,460	+175%	+$2.21M	0.4%	65
2024 Q2	$1.27M	Buy	+1,408	New	+$1.13M	0.41%	60
2023 Q1	–	Sell	-12	Closed	-$4.39K	–	816
2022 Q4	$4.39K	Buy	+12	New	+$4.25K	﹤0.01%	705
2021 Q2	–	Sell	-22,861	Closed	-$4.59M	–	1172
2021 Q1	$4.27M	Buy	+22,861	New	+$4.47M	0.05%	394
2020 Q4	–	Sell	-1,176	Closed	-$176K	–	877
2020 Q3	$174K	Buy	+1,176	New	+$182K	﹤0.01%	444
2020 Q2	–	Sell	-15,300	Closed	-$2.35M	–	441
2020 Q1	$2.12M	Buy	+15,300	New	+$2.1M	0.22%	94

Other funds holding LLY

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

CAAS Capital Management's LLY Position: Q1 2025 in Review

CAAS Capital Management reduced its Eli Lilly (LLY) stake by 31% in Q1 2025, selling an estimated $631K and leaving 1,650 shares worth $1.36M. The position accounts for 0.15% of the portfolio, ranked #146.

CAAS Capital Management first reported a position in LLY in Q1 2020 and has held it in 8 quarters since. The position peaked at $4.27M in Q1 2021. 3,919 funds tracked by Wall St. Rank hold LLY as of Q1 2025.

CAAS Capital Management held 1,650 shares of Eli Lilly worth $1.36M as of Q1 2025.
CAAS Capital Management sold 758 Eli Lilly shares in Q1 2025, an estimated $631K.
Eli Lilly made up 0.15% of CAAS Capital Management's portfolio in Q1 2025, its #146 holding.
CAAS Capital Management first reported a position in Eli Lilly in Q1 2020 and has held it in 8 quarters since.
CAAS Capital Management's Eli Lilly position peaked at $4.27M in Q1 2021.
3,919 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2025.

Based on CAAS Capital Management's 13F filing for Q1 2025, filed 1 May 2025.